Norwegian Radium Hospital

Oslo N-0310

0 studies enrolling now · 14 studies all time

What they study most

Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Gestational Trophoblastic Tumor, Malignant Pleural Mesothelioma, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Sarcoma

Studies at this site

• A Study of R1507 in Participants With Recurrent or Refractory Sarcoma — Stopped early
• Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer — Completed
• Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma — Stopped early
• Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) — Completed
• Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
• Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia — Completed
• Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer — Stopped early
• Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer — Completed
• Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy — Completed
• Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer — Completed
• Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus — Stopped early
• Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix — Stopped early
• Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer — Completed